⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AARD
Bronstein, Gewirtz & Grossman LLC Urges Aardvark Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
AARD
AARD UPCOMING DEADLINE: Levi & Korsinsky Alerts Aardvark Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
accessnewswire.com
AARD
AARD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026
accessnewswire.com
AARD
Class Action Filed by Pomerantz LLP Concerning Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Levi & Korsinsky Urges Aardvark Therapeutics, Inc. (AARD) Shareholders to Act Before Lead Plaintiff Deadline October 13, 2026
accessnewswire.com
AARD
Contact Levi & Korsinsky by October 13, 2026 to Join Class Action Against Aardvark Therapeutics, Inc. (AARD)
accessnewswire.com
AARD
Class Action Lawsuit Filed Against Aardvark Therapeutics, Inc. (AARD) - Recover Losses - Contact Levi & Korsinsky Before October 13, 2026
accessnewswire.com
AARD
AARD DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important October 13 Deadline in Securities Class Action – AARD
globenewswire.com
AARD
Form 8-K
sec.gov
AARD